Members
Consortium members and collaborators
Alexandre Lehmann
π Canada
McGill University, Canada
Research Interests
Real-world data, practice-based research network, informing policy, music and plasticity
Alexis Arragon
π France
French Psychedelic Society/ PsychedeliCare
Research Interests
Advocacy for psychedelic therapies, policy work in Europe, general public destigmatization and education
Brock Pluimer
π USA
University of California, Irvine
Research Interests
ibogaine, opioid use disorder
Daniel J. Kruger
π USA
University at Buffalo; University of Michigan
Research Interests
Survey research, many topics
Diego Pinzon Rubiano
ContactEduardo Schenberg
π Portugal
Faculty of Medicine, University of Lisbon, Portugal
Research Interests
epistemology, evidence assessments, trial designs, social justice, ethics, indigenous rights, history, mechanisms and more
Farnaz Younessi Sisi
π Iran
Yaadmaan Institute for Brain, Cognition and Memory Studies, Tehran, Iran; Cognitive Neurology and Neuropsychiatry Research Center, Tehran University of Medical Sciences (TUMS), Tehran, Iran
Research Interests
Mechanisms of therapeutic action; Domain-based, neuroscience-informed investigation of psychedelics in neurological conditions
Futaba Ummeura
π Japan
Niigata University Graduate School, Tokyo Metropolitan institute of Medicine Science (TMiMS), National Center of Neurology and Psychiatry (NCNP), Japan
Research Interests
Real World Psychedelic Use, Harm Reduction, Online Survey, PAT
Galia J Benitez
π USA
Michigan State University
Research Interests
Psychedelics, ritual uses, other uses, indigenous uses, sources, government policies or regulations
Julio Cesar Camargo Silva
π Canada
University of British Columbia (UBC) - alumnus
Research Interests
Psychedelic Assisted Therapy (PAT); mental health; psychiatry; treatment methodology; cultural aspects of substance use; community-based research; indigenous rights
Kari Rockhill
π USA
Rocky Mountain Poison & Drug Safety
Research Interests
real-world psychedelic use, epidemiological surveillance, safety monitoring
Katie Pickard
Unlimited Sciences
Research Interests
Real world psychedelic use, evidence-based education, harm reduction, policy change
Kristel Carrington
Doctors for Drug Policy Reform
Research Interests
Evidence-based drug policy reform, education, access to psychedelics, decriminalization
Kyle Greenway
π Canada
McGill University
Research Interests
Therapeutic applications, music, phenomenology
Lani Roy
π Australia
Chair, Australian Multidisciplinary Association Psychedelic Practitioners
Research Interests
harm reduction, preparation, integration, PTSD/sexual abuse - all areas
LucΓa Levenberg
π Argentina
Independent
Research Interests
Real world bond with entheogens and psychedelics data, neuroaffirmative and gender affirmative practices in psychedelics, policy change for safe access, ethics, professionals continue education, chronic illness
Mahmoud Elmidany
π UK
cambridge university hospitals
Research Interests
Qualitative experiences of real world use of psychedelics
Matthew Hicks
π USA
National University of Natural Medicine; Synaptic Institute
Research Interests
Ketamine, Psilocybin, 5-MeO-DMT research focused on depression, PTSD and accessibility
Michel Dorval
π Canada
UniversitΓ© Laval, QuΓ©bec, Canada
Research Interests
Palliative care; psilocybin-assisted therapy; epidemiology
Michelle St. Pierre
π Canada
UBC; BC Centre on Substance Use (BCCSU)
Research Interests
Psychedelics (incl. microdosing, ketamine), cannabis, mental health
Niloufar Pouyan
π USA
University of Michigan
Research Interests
Mechanisms of therapeutic action; Domain-based, neuroscience-informed investigation of psychedelics in psychiatric conditions and chronic pain
Omer Syed
π Canada
University of Toronto
Research Interests
Real world psychedelic use, microdosing, ketamine
Pamela Kryskow
π Canada
UBC/VIU/Roots To Thrive
Research Interests
Real patients, real therapy, real outcomes
Paul Liknaitzky
π Australia
Monash University, Australia
Research Interests
Clinical trials, psychedelic psychotherapies, psychedelic-catalysed insight, therapist training, psychedelic-assisted training, extended uses of PAT
Pedram Dara
Psychedelic Lived Experiences
Research Interests
Lived experience expertise (clinical trial participants and patients)
Pedro Teixeira
π Portugal
University of Lisbon - Faculty of Human Kinetics
Research Interests
Psychedelics, health behaviors, prevention, public health
Philippe Lucas
π USA
MAPS/Michigan Psychedelic Center
Research Interests
Real World psychedelic use
Pinni (Pinchas) Baumol
π Israel
Tel-aviv University, Shaare Nefesh resilience center, ACPT
Research Interests
PAT for PTSD/Harm reduction/Policy change social work
Rick Harris
π USA
University of California, Irvine
Research Interests
Psychedelics for chronic pain and opioid addiction
Rotem Petranker
π Canada
Canadian Centre for Psychedelic Science AND ALSO McMaster University
Research Interests
Psychedelics; microdosing; open science; methodology; clinical trial design
Sam Lasham
π New Zealand
University of Auckland, New Zealand, Students for Sensible Drug Policy Aotearoa New Zealand
Research Interests
Real world use of psychedelics, harm reduction, drug checking, and beneficial illicit drug use
Sara de la Salle
π Canada
McGill University
Research Interests
Psychedelics and music, mindfulness, absorption, imprinting (visual hallucinations)
Sara Gloeckler
π Canada
McGill University
Research Interests
Psychedelics and music, social determinants of health
Sue-Ling Chang
π Canada
Centre de recherche du CHU de QuΓ©bec-UniversitΓ© Laval, QuΓ©bec, Canada
Research Interests
Palliative care, psilocybin-assisted therapy, epidemiology
Toshihiko Matsumoto
π Japan
Department of Drug Dependence Research at the National Center of Neurology and Psychiatry (NCNP), Japan
Research Interests
Substance Use Disorder treatment, Harm Reduction, Policy, Psychedelic use in Japan
TΓΊlio Pereira Alvarenga e Castro
π Brazil
Universidade Federal dos Vales do Jequitinhonha e Mucuri
Research Interests
DMT; Psilocybin; psychiatry; addiction medicine; medical anthropology; community; traditional healing; nature relatedness
Vincent Joralemon
π USA
Director, Berkeley Law Life Sciences Law & Policy Center
Research Interests
FDA Approval, patents, commercialization, decriminalization, policy, federalism
Zach Walsh
π Canada
University of British Columbia
Research Interests
psychedelics and cannabis for problematic substance use; psychedelic access

